RevistaLab
Boston’s Urban Edge submarket for Life Science (LS) has been one of the epicenters of occupancy declines observed within the LS real estate sectors the past few years. In 2020, the 2.2 million square feet of LS space within Urban Edge was virtually 100% occupied. By the end of 2025 there were over 6 MSF of LS inventory in the market, of which half were vacant. The Urban Edge’s LS occupancy stood at 49.3% in 4Q25.
After $19.7B traded in 2021, transaction activity has slowed each year after and has established a current bottom in 2025 with just $3.8 billion traded. But activity appears to be picking up. So far in 2026 . . .
he Worcester Life Science market lies in Central Massachusetts (MA) and serves as a natural growth point for life science companies looking to grow from the Boston/Cambridge CBSA.
The US Life Science or Biotech real estate sector has seen tremendous growth during the past 3 years. Overall, since 2Q22, the US Life Science sector has grown by 17% to 401 million square feet (MSF) in 2Q25.
The Life Science Real Estate (LSRE) sector, like many other commercial real estate sectors, has seen transaction activity slow in recent years. Higher interest rates have created an uneasy investing and lending environment. The LSRE sector . . .
The chart below shows aggregate LSRE trends in the top 3 markets from 2Q22 to 4Q24. It represents almost 150 million square feet tracked by RevistaLab.com in these 3 markets.
For those tracking the Life Science Real Estate Sector (LSRE) it should be no surprise that supply is growing currently.
In fact, the overall US occupancy rate is currently 89.7% as of 2Q24 and is down 320 basis points from 2Q23. The occupancy rate declines have been largely supply driven as the overall US inventory has grown by over 6% during the past year.
Over the past couple of years, life science real estate occupancy has been on the decline in the top markets. The top 3 markets represent over 1/3 of the US inventory and have the longest history as biotech clusters. Prior to 2022, there was generally a nice balance between . . .
RevistaLab.com recently held its 4th quarter life science real estate update. Revista principals, Hilda Martin and Mike Hargrave presented RevistaLab data on construction trends, transactions, occupancies, supply/demand fundamentals across the …
It is no secret that inventory has been increasing lately in many life science real estate markets. Developers have been responding to increasing demand for new space during the past years, especially coming out of the COVID-19 pandemic era
Life Science real estate transaction volume picked up at the end of 2023, according to newly released data from www.revistalab.com.
The life science real estate construction pipeline, which had been rising throughout 2022 is beginning to show signs of stabilization. Measured by square feet in progress (SF Inprogress), Revistalab calculates …
Revistalab.com has been tracking vacancies and has an emerging time series available in several life science markets, including the 3 largest – Boston, San Diego and San Francisco/San Jose. When …
Did you know Revistalab tracks life science real estate (LSRE) construction across the country? RevistaLab covers lab construction projects, including conversions expansions and new properties across the US that are in planning, in progress as well as completed.
Did you know that www.revistalab.com is tracking real estate transaction activity within the Life Science Real Estate Sector? We have trend data on transaction volumes, prices per square foot, and even cap rates starting in 2020 to present.
In place rents have been on the rise within the Life Science sector’s top 3 markets (Boston, San Diego and San Francisco). Data is gathered by https://www.revistalab.com/ and is based on leases commencing …